Stock NARA PANGENOMIC HEALTH INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pangenomic Health Inc.

Equities

NARA

CA69842E3041

Delayed Canadian Securities Exchange
Other stock markets
 10:27:36 2024-04-30 am EDT 		5-day change 1st Jan Change
0.08 CAD 0.00% Intraday chart for Pangenomic Health Inc. 0.00% -60.00%
Feb. 19 PanGenomic Health plans to withdraw shares from Aquis Stock Exchange AN
Feb. 16 Pangenomic Health Inc. Announces Changes to Board of Directors CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements
AQ
PanGenomic Health Announces Completion of Consolidation
AQ
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)
NE
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE
AQ
PanGenomic Health Announces Withdrawal from AQSE
AQ
PanGenomic Health plans to withdraw shares from Aquis Stock Exchange
AN
PanGenomic Health Announces Changes to Board of Directors
AQ
Pangenomic Health Inc. Announces Changes to Board of Directors
CI
PanGenomic Health agrees non-binding drawdown facility with Crescita
AN
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility
AQ
PanGenomic subsidiary reveals point-of-care vitamin D test
AN
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry
MT
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry
AQ
Pangenomic Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way
NE
PanGenomic Health's MUJN sells first biomarker tests
AN
PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests
AQ
PanGenomic Health Intends to Close Shares for Debt Settlement
AQ
PanGenomic Health interim loss widens amid higher costs
AN
PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NARA Stock
  4. News Pangenomic Health Inc.